Feedback

Feedback R&D per Employee

The R&D Spending per Employee of Feedback (FDBK.L) as of Nov 4, 2026 is 44,937.60 GBP. In the previous year, R&D Spending per Employee was 37,295.32 GBP — a change of 20.49% (higher).

R&D per Employee

44,937.60GBP

YoY

20.49%

Last updated:

R&D Spending per Employee of Feedback is 2025 44,937.60 GBP. R&D Spending per Employee of Feedback was 2024 37,295.32 GBP. It decreases by 20.49% higher compared to the previous year.

The Feedback R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2015
5,123.96 GBP
Jan 1, 2016
2,141.60 GBP
Jan 1, 2017
1,435.88 GBP
Jan 1, 2019
3,296.68 GBP
Jan 1, 2022
21,008.52 GBP
Jan 1, 2023
31,255.76 GBP
Jan 1, 2024
37,295.32 GBP
Jan 1, 2025
44,937.60 GBP
The Feedback R&D per Employee history
YEARR&D per EmployeeYoY
44,937.60GBP+20.49%
37,295.32GBP+19.32%
31,255.76GBP+48.78%
21,008.52GBP+537.26%
3,296.68GBP+129.59%
1,435.88GBP-32.95%
2,141.60GBP-58.20%
5,123.96GBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Feedback Stock analysis

What does Feedback do? Feedback PLC provides imaging tools for clinical decision makers, including TexRAD for medical research and clinical trial management, and Cadran for medical imaging decision support. The company offers Cadran Image Storage Management for image display, review, and enterprise archiving across clinical, non-clinical, and teaching environments. Subsidiaries such as Feedback Black Box Company Limited, Feedback Data GmbH, Brickshield Limited, Cambridge Computed Imaging Limited, TexRAD Limited, and Prostate Checker Ltd support its operations. The firm generates revenue through these products and services targeting medical practitioners, researchers, and pharmaceutical companies involved in cancer detection and treatment workflows. TexRAD is utilized by pharmaceutical companies for managing clinical trials and research, while Cadran and Cadran Image Storage Management are sold to healthcare providers and institutions requiring advanced imaging solutions. The company’s focus on imaging biomarkers for cancer detection attracts partnerships with medical research organizations and hospitals seeking to improve diagnostic accuracy and patient outcomes. Feedback Data GmbH and TexRAD Limited specifically contribute to the development and management of imaging techniques and workflow solutions for the medical sector. The business model centers on selling specialized imaging software and tools to healthcare institutions, pharmaceutical firms, and research organizations. Products like Cadran Image Storage Management are designed for enterprise-level archiving and image handling, appealing to large healthcare systems and academic institutions. TexRAD’s role in clinical trial management ensures recurring revenue streams from pharmaceutical clients who rely on its platform for trial execution and data management. Feedback is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Feedback stock

R&D Spending per Employee of Feedback is 44,937.60 GBP in 2025.

R&D Spending per Employee of Feedback changed from 37,295.32 GBP to 44,937.60 GBP, representing a 20.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Feedback since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Feedback historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Feedback

All Key Metrics — Feedback